scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1067-1927.2004.012411.X |
P698 | PubMed publication ID | 15260806 |
P50 | author | Claus Bachert | Q55233350 |
P2093 | author name string | Cindy Claeys | |
Paul Van Cauwenberge | |||
Jean-Baptiste Watelet | |||
P2860 | cites work | Transforming growth factor beta in tissue fibrosis | Q28239292 |
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients | Q28366039 | ||
The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease | Q40596987 | ||
Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. | Q40607050 | ||
Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer | Q40627729 | ||
Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma | Q40713063 | ||
Towards a biological staging model for operable non-small cell lung cancer | Q47573495 | ||
Determination of endogenous growth factors in human wound fluid: temporal presence and profiles of secretion | Q47877571 | ||
Secretion of TGF-betal, TGF-beta2, EGF and PDGF into nasal fluid after sinus surgery | Q49044596 | ||
The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. | Q50664883 | ||
Matrix metalloproteinase 9 level predicts optimal collagen deposition during early wound repair in humans. | Q54084793 | ||
P433 | issue | 4 | |
P304 | page(s) | 412-418 | |
P577 | publication date | 2004-07-01 | |
P1433 | published in | Wound Repair and Regeneration | Q3538612 |
P1476 | title | Predictive and monitoring value of matrix metalloproteinase-9 for healing quality after sinus surgery | |
P478 | volume | 12 |
Q38736622 | Biomarkers in the evaluation and management of chronic rhinosinusitis with nasal polyposis |
Q49137965 | Chronic rhinosinusitis with and without nasal polyps: what is the difference? |
Q37022936 | Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. |
Q45891681 | Is it really necessary to delay intranasal steroid treatment after FESS? An animal study |
Q33597144 | Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis |
Q33660754 | Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics |
Q24634722 | Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses. |
Q34415626 | Structural organization and cellular localization of tuftelin-interacting protein 11 (TFIP11). |
Q36361570 | The effects of the stem cell on ciliary regeneration of injured rabbit sinonasal epithelium |
Q36604438 | Tissue remodelling in upper airways: where is the link with lower airway remodelling? |
Q59620695 | Wundheilung und postoperative Behandlung nach Nasennebenhöhlenoperationen |
Search more.